je.st
news
Tag: therapeutics
Five Prime Therapeutics: Ridiculously Undervalued
2015-10-17 20:45:28| Biotech - Topix.net
Five Prime trades at a ridiculously low enterprise value of ~ $280 Million after a $1.74 Billion deal with Bristol Myers Squibb. Five Prime is sitting on ~$520 Million in cash and still has a highly effective discovery platform and wholly owned assets.
Tags: prime
therapeutics
undervalued
BASF to Develop a High Purity Poloxamer for Mast Therapeutics
2015-10-13 15:03:22| Chemicals - Topix.net
Currently, excipient-grade poloxamer 188 NF, marketed by BASF under the KolliphorA P188 brand, is a polymer used in a variety of pharmaceutical and biological applications, such as a shear protectant in cell culture production. Poloxamer 188 is the starting material for Mast's lead product candidate.
Tags: high
develop
purity
mast
After-Hours Moves Led By Orexigen Therapeutics, EMC, Clean Energy Fuels And Cadiz
2015-10-10 23:35:08| Agriculture - Topix.net
Orexigen Therapeutics, Inc. was the biggest gainer in Friday's after-hours session. The stock, which surged 6.3 percent over the day on news of The Baupost Group having reported a 17.17 percent stake in the small-cap biopharmaceutical company, continued to rise after the bell, up more than 12 percent.
Macrophage Therapeutics Produces First Two Immunoconstructs
2015-09-28 06:00:20| chemicalonline Home Page
Macrophage Therapeutics, Inc., a subsidiary of Navidea Biopharmaceuticals, Inc., recently announces that it has developed a process for producing the first two therapeutic Manocept immunoconstructs, MT-1001
Tags: produces
therapeutics
Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences
2015-09-02 07:53:29| drugdiscoveryonline News Articles
Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, recently announced the acquisition of Cardiogen Sciences, Inc., a biotechnology company focused on the discovery and development of adeno-associated virus(AAV) gene therapy products for rare, inherited arrhythmogenic diseases
Tags: company
sciences
therapy
gene
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »